FDA Video: Black Box Warning Added to Reglan® – Tardive Dyskinesia
Below, is a video published by the U.S. Food & Drug Adminsitration (FDA), which discusses the “Black Box” warning and the increased risk of the development of Tardive Dyskinesia among users of Reglan.
Learn More:
- Reglan Lawsuit
- Tardive Dyskinesia Lawsuit
- FDA Requires Boxed Warning and Risk Mitigation Strategy for Metoclopramide-Containing Drugs (pdf)
Do I have a Reglan Tardive Dyskinesia Lawsuit?
The Defective Drug and Product Liability litigation Groups at our law firm are an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Tardive Dyskinesia lawsuits. We are handling individual lawsuits nationwide and currently accepting new Reglan induced Tardive Dyskinesia cases in all 50 states.
If you or a loved one have taken Reglan (Generic name: Metoclopramide) and been diagnosed with Tardive Dyskinesia, you should contact us immediately. You may be entitled to compensation and we can help.
To contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
